Smoking Cessation and Nicotine De-Addiction Products Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Smoking Cessation and Nicotine De addiction Products Market: By Product Type (Nicotine Based Products (Nicotine Gums, Nicotine Patches, Nicotine Sprays, Nicotine Inhalers, and Nicotine Lozenges) Electronic Cigarette, and Non-nicotine Products (Varenicline, Bupropion, Cytisine)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Retail Stores), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Global Smoking Cessation and Nicotine De-addiction Products Market was valued at US$ 9,015 Mn in 2021 and is anticipated to grow at US$ 18,499 Mn by 2028 recording a CAGR of 12.8% during the forecast period 2022-2028. Smoking Cessation and Nicotine De-addiction Products Market Of late, several governments across the globe coming up with policy changes to curb the smoking habit among people, which is likely to prompt smokers to adopt alternatives to smoking such as nicotine-based products or E-cigarettes. Moreover, several governments are launching innovative awareness campaigns through digital, electronic and print media to sensitize the people regarding harmful effects of the smoking. These government initiatives expected to drive the market for smoking cessation & nicotine de-addiction products over the forecast period. For Instance, countries/regions like China, India and GCC countries brought laws that mandate the tobacco products manufacturers to place warning labels on the products and same laws prohibit the smoking in public areas, these are expected to create a market opportunity for the players. Players in smoking cessation & nicotine de-addiction products market are focusing on introducing newer and innovative therapies like varenicline and Cytisine to garner larger market revenue share in global smoking cessation & nicotine de-addiction products market. Moreover, players entering into collaborations and partnership to increase the product market reach in various geographies

 

Smoking Cessation and Nicotine De addiction Products Market

MARKET SUMMARY
-
12.8%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 12.8%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

smoking cessation and nicotine de-addiction

  •  The report on smoking cessation & nicotine de-addiction products market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, distribution channel, and geographic regions.
  • This report studies smoking cessation & nicotine de-addiction products market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • In addition, smoking cessation & nicotine de-addiction products market report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
  • Moreover, PBI analyzed smoking cessation & nicotine de-addiction products market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
  • Key stakeholders of the smoking cessation & nicotine de-addiction products market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in manufacturing, supply and prescription of Smoking Cessation and Nicotine De-addiction Products Market
Market Key Players
  • Cipla Ltd.
  • GlaxoSmithKline plc.
  • ITC Limited
  • Johnson & Johnson Services Inc
  • NJOY, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Takeda Pharmaceuticals Co. Ltd.
  • VMR Products, LLC
Growth

Smoking Cessation and Nicotine De-addiction Products Market

The growing prevalence of smoking and its hazardous effects on the cardiac and respiratory system is driving the smokers to adopt an alternative to smoking like nicotine-based products and E-cigarettes, this is expected to create a huge growth opportunity for market players over the forecast period. Moreover, consumers have been exposed to numerous innovative products in different formulations, which are helping buyers to choose the appropriate product for consumption, this in turn aiding the product adoption in the market. Moreover, regulatory approvals for Nicotine Replacement Therapies (NRT), non-nicotine based products and e-cigarettes are aiding the market revenue growth.


North-America Got Significant Share

smoking cessation & nicotine de-addiction products market

North America market is expected to hold the larger revenue share in global smoking cessation & nicotine de-addiction products market and projected to remain dominant over the forecast period owing to growing awareness and wider adoption choices in the region. Asia-pacific Smoking cessation & nicotine de-addiction products market projected to grow at highest CAGR over the forecast period in comparison with other regions owing to large smoking population and growing interest of multinational players in the region for geographic expansion.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Key Findings of the Report

Keloid Treatment Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Research Methodology
    • Secondary and Primary research
      • Secondary Sources
      • Primary Sources
    • Market Revenue Estimation Methodology
    • Key Assumptions
    • Acronyms
  2. Scope of Study
    • Market Definition
    • Objective of the Research
    • Regions covered in the study
  3. Executive summary
  4. Global Smoking Cessation and Nicotine De-addiction Products Market Dynamics
    • Drivers
      • Economic Drivers
      • Demand Side Drivers
      • Supply Side Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
  5. Unique Features of the Report
    • Competition analysis
    • Regulatory landscape
    • PESTLE analysis
    • Porter’s analysis
  6. Global Smoking Cessation and Nicotine De-addiction Products Market Analysis, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Nicotine Based Products (Nicotine Gums, Nicotine Patches, Nicotine Sprays, Nicotine Inhalers, and Nicotine Lozenges)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Electronic Cigarette
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Non-nicotine Products (Vareniclin, Bupropion, and Cytisine)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Smoking Cessation and Nicotine De-addiction Products Market Forecast, By Distribution Channel Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Hospital Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Retail Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Online Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Retail Stores
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Smoking Cessation and Nicotine De-addiction Products Market Analysis, By Region, 2013 – 2017 and Forecast, 2018 – 2024
    • North America Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
  2. 1.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
    • Nicotine Based Products
      • Nicotine Gums
      • Nicotine Patches
      • Nicotine Sprays
      • Nicotine Inhalers
      • Nicotine Lozenges
    • Electronic Cigarette
    • Non-nicotine Products
      • Vareniclin
      • Bupropion
      • Cytisine
    • Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Retail Stores
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • US
      • Canada
    • Europe Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
  3. 2.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
    • Nicotine Based Products
      • Nicotine Gums
      • Nicotine Patches
      • Nicotine Sprays
      • Nicotine Inhalers
      • Nicotine Lozenges
    • Electronic Cigarette
    • Non-nicotine Products
      • Vareniclin
      • Bupropion
      • Cytisine
    • Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Retail Stores
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Poland
      • Rest of Europe
    • Asia-Pacific Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
  4. 3.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
    • Nicotine Based Products
      • Nicotine Gums
      • Nicotine Patches
      • Nicotine Sprays
      • Nicotine Inhalers
      • Nicotine Lozenges
    • Electronic Cigarette
    • Non-nicotine Products
      • Vareniclin
      • Bupropion
      • Cytisine
    • Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Retail Stores
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  5. Y-o-Y Growth (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Latin America Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
  1. 4.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
    • Nicotine Based Products
      • Nicotine Gums
      • Nicotine Patches
      • Nicotine Sprays
      • Nicotine Inhalers
      • Nicotine Lozenges
    • Electronic Cigarette
    • Non-nicotine Products
      • Vareniclin
      • Bupropion
      • Cytisine
    • Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Retail Stores
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  2. Y-o-Y Growth (%)
    • Brazil
    • Mexico
    • Argentina
    • Venezuela
    • Rest of Latin America
  • Middle East & Africa (MEA) Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
  1. 5.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
    • Nicotine Based Products
      • Nicotine Gums
      • Nicotine Patches
      • Nicotine Sprays
      • Nicotine Inhalers
      • Nicotine Lozenges
    • Electronic Cigarette
    • Non-nicotine Products
      • Vareniclin
      • Bupropion
      • Cytisine
    • Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)

Report

Company Profile

  • Cipla Ltd. (India)
  • GlaxoSmithKline plc. (UK)
  • ITC Limited (India)
  • Johnson & Johnson Services Inc. (U.S)
  • NJOY, Inc. (U.S)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (U.S)
  • Takeda Pharmaceuticals Co. Ltd. (Japan)
  • VMR products, LLC (U.S)

Description

Global Smoking Cessation and Nicotine De-addiction Products Market was valued at US$ 9,015 Mn in 2021 and is anticipated to grow at US$ 18,499 Mn by 2028 recording a CAGR of 12.8% during the forecast period 2022-2028. Smoking Cessation and Nicotine De-addiction Products Market Of late, several governments across the globe coming up with policy changes to curb the smoking habit among people, which is likely to prompt smokers to adopt alternatives to smoking such as nicotine-based products or E-cigarettes. Moreover, several governments are launching innovative awareness campaigns through digital, electronic and print media to sensitize the people regarding harmful effects of the smoking. These government initiatives expected to drive the market for smoking cessation & nicotine de-addiction products over the forecast period. For Instance, countries/regions like China, India and GCC countries brought laws that mandate the tobacco products manufacturers to place warning labels on the products and same laws prohibit the smoking in public areas, these are expected to create a market opportunity for the players. Players in smoking cessation & nicotine de-addiction products market are focusing on introducing newer and innovative therapies like varenicline and Cytisine to garner larger market revenue share in global smoking cessation & nicotine de-addiction products market. Moreover, players entering into collaborations and partnership to increase the product market reach in various geographies

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX